Are risk evaluation and mitigation strategies associated with less off-label use of medications? The case of immune thrombocytopenia.
about
Are risk evaluation and mitigation strategies associated with less off-label use of medications? The case of immune thrombocytopenia.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Are risk evaluation and mitiga ...... se of immune thrombocytopenia.
@ast
Are risk evaluation and mitiga ...... se of immune thrombocytopenia.
@en
type
label
Are risk evaluation and mitiga ...... se of immune thrombocytopenia.
@ast
Are risk evaluation and mitiga ...... se of immune thrombocytopenia.
@en
prefLabel
Are risk evaluation and mitiga ...... se of immune thrombocytopenia.
@ast
Are risk evaluation and mitiga ...... se of immune thrombocytopenia.
@en
P2093
P2860
P356
P1476
Are risk evaluation and mitiga ...... ase of immune thrombocytopenia
@en
P2093
A Sarpatwari
J D Seeger
J E Landon
J M Franklin
P2860
P304
P356
10.1002/CPT.17
P407
P577
2014-12-20T00:00:00Z